NANO-ENGINEERED ANTIDOTES: REVOLUTIONIZING PRECISION THERAPY IN MODERN TOXICOLOGY

Abstract

Nano-engineered antidotes represent a transformative advancement in modern pharmacology and toxicology by integrating nanotechnology with precision medicine to improve therapeutic efficacy, target specificity, and toxicological safety. Conventional antidotal therapies often suffer from limitations such as poor bioavailability, systemic toxicity, rapid metabolism, and inadequate tissue targeting. Nanotechnology-based therapeutic systems including liposomes, polymeric nanoparticles, dendrimers, nanozymes, metallic nanoparticles, and lipid-based nanocarriers provide innovative solutions for overcoming these limitations. These nanoformulations enable controlled drug release, enhanced pharmacokinetics, selective organ targeting, and improved detoxification mechanisms against poisons, heavy metals, organophosphates, venoms, and oxidative toxicants. Recent developments in artificial intelligence-driven nanomedicine and precision toxicology have further enhanced predictive toxicological modeling and personalized antidote delivery strategies. Nano-engineered antidotes also demonstrate promising applications in neurotoxicity, hepatotoxicity, cardiotoxicity, and environmental toxicology through mechanisms involving reactive oxygen species scavenging, enzyme mimicking, and targeted molecular neutralization. However, concerns regarding nanoparticle-induced toxicity, biodistribution, long-term accumulation, immunogenicity, and regulatory challenges remain significant barriers to clinical translation. Emerging approaches such as biodegradable nanoparticles, organ-on-chip testing systems, machine learning-assisted toxicity prediction, and nano-QSAR models are reshaping the future of safe nanotherapeutics. This article comprehensively explores the pharmacological principles, toxicological implications, therapeutic applications, translational challenges, and future prospects of nano-engineered antidotes in precision toxicology. The integration of nanotechnology with pharmacology offers immense potential for developing next-generation antidotal therapies capable of achieving highly effective and patient-specific detoxification strategies in clinical medicine.